ReviewClinics in chest medicine2025
Measurement and Significance of the Diffusing Capacity of the Lung for Carbon Monoxide.
Review in Clinics in chest medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Association of Serum KL-6 with Functional Impairment in Patients with Immune-Mediated Interstitial Lung Disease.Medicina (Kaunas, Lithuania) · 2026Article
- Correlations between quantitative computed tomography metrics with serum fibrosis biomarkers, pulmonary function, and mortality risk in patients with idiopathic pulmonary fibrosis: a prospective cohort study.Journal of thoracic disease · 2026Article
- Diffusing Capacity of the Lung for Carbon Monoxide and the Risk of All-Cause Mortality in Patients With Pulmonary Hypertension Caused by Fibrosing Mediastinitis: A Multicenter Cohort Study.Pulmonary circulation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Diffusing capacity of the lung for carbon monoxide (DLCO) is a valuable pulmonary function test that can guide diagnostic evaluation, treatment strategies, and prognostic assessment in clinical practice. The test examines the underlying pathophysiology guiding transfer of oxygen from alveoli into the blood. Measurement of DLCO requires patients to perform a simple maneuver of inhalation and breath holding, and results can be influenced by both testing and patient factors of which clinicians should be aware. Gas transfer measurement captures 2 components, alveolar volume and the transfer coefficient, that can further distinguish the many underlying processes that result in DLCO impairment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.